➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Johnson and Johnson
Medtronic
McKinsey
Baxter

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Biovail Labs Intl Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BIOVAIL LABS INTL, and what generic and branded alternatives to BIOVAIL LABS INTL drugs are available?

BIOVAIL LABS INTL has four approved drugs.



Summary for Biovail Labs Intl
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Biovail Labs Intl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail Labs Intl CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET, ORALLY DISINTEGRATING;ORAL 021763-002 Dec 20, 2005 DISCN No No   Start Trial   Start Trial
Biovail Labs Intl CARDIZEM diltiazem hydrochloride INJECTABLE;INJECTION 020027-003 Aug 18, 1995 DISCN Yes No   Start Trial   Start Trial
Biovail Labs Intl VASOTEC enalaprilat INJECTABLE;INJECTION 019309-001 Feb 9, 1988 DISCN Yes No   Start Trial   Start Trial
Biovail Labs Intl TOVALT ODT zolpidem tartrate TABLET, ORALLY DISINTEGRATING;ORAL 021412-001 Apr 25, 2007 DISCN No No   Start Trial   Start Trial
Biovail Labs Intl CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET, ORALLY DISINTEGRATING;ORAL 021763-003 Dec 20, 2005 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Moodys
Harvard Business School
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.